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SCANNING ELECTRON MICROS-
COPY OF LEUKAEMIC AND
LYMPHOMA CELLS
E. DE HARVEN, Sloan-Kettering Institute for
Cancer Research, New York.
The significance of scanning electron
microscopy in the characterization of the
surface architecture of human normal and
malignant lymphocytes was reviewed. The
different preparatory techniques which can
be applied to suspensions of lymphoid cells
were critically evaluated. Special attention
was given to cell sampling and efforts to
obtain high yield samples. Problems of
resolution ofthe SEM, ofcritical point drying
methods and the necessity of a conductive
coating of the examined cell surfaces was
considered. Recent observations with virus
(TMV) markers were illustrated and their
potential in cell type identification as well as
in the " mapping " of cell surface antigens
were analysed. Clinical applications of
scanning electron microscopy to the study of
human lymphocytes were summarized, with
special attention to 85 cases of acute and
chronic lymphocytic leukaemia (CLL and
ALL) and related lymphoproliferative dis-
orders. While a spectrum of surface
morphologies was observed in most cases of
CLL, it appeared that in ALL (or un-
differentiated leukaemias) the circulating
cells are consistently characterized by gener-
ally smooth surfaces.
Monocytic features in the " hairy cells"
of leukaemic reticuloendotheliosis were
illustrated, as well as the alterations in the
surface structures of T derived lymphocytes
after rosetting with sheep erythrocytes.
GENETIC MARKERS AND THE
ORIGIN OF HUMAN NEOPLASMS
P. J. FIALKOW, Professor of Medicine and
Genetics, University of Washington; Chief,
Medical Service, Veterans Administration
Hospital, Seattle, Wa.
Because direct studies of the origin and
development of tumours cannot be done in
man, most investigations of human tumouri-
genesis provide only indirect evidence about
causative factors. One such indirect tech-
nique involves the use of naturally occurring
cell labels (genetic markers) to determine the
number of cells from which tumours arise,
thereby providing important clues to their
mode of origin. For example, a neoplasm
that results from a rare random event like
" spontaneous " somatic mutation would be
expected to arise in a single cell. In contrast,
multicellular origin would be anticipated for a
tumour caused by cell-to-cell spread and
transformation by a virus.
One way to approach this problem is to
study tumours from persons with at least two
genetically distinct types of cells. Both cell
types will be found in normal tissue, but
neoplasms with clonal origin will exhibit only
one type. Especially useful for this purpose
is the cellular mosaicism of females hetero-
zygous for a gene on the X chromosome such
as the one for glucose-6-phosphate dehydro-
genase (G-6-PD). In accordance with the
inactive-X (Lyon) hypothesis, only one ofthe
two X chromosomes in females is active in
each somatic cell. Thus, females hetero-
zygous at the X-linked G-6-PD locus for the
usual gene (GdB) and the common variant
GdA have two cell populations, one producing
the G-6-PD type B, and the other, type A.
Tumours with a clonal origin in GdB/G A
heterozygotes exhibit only one type of
enzyme (A or B); whereas, those arising from
many cells may have both A and B enzymes.
We initially applied this experimental
approach to the study of chronic myelocytic
leukaemia (CML). Although both B and A
enzymes were present in skin, each of five
G-6-PD heterozygotes with CML had only a
single enzyme type in their CML blood
granulocytes (3 had type A G-6-PD and 2
had B). In contrast to these findings in
CML, 34 non-leukaemic G-6-PD hetero-
zygotes with double enzyme phenotypes in
skin always displayed both A and B enzymes
in blood granulocytes. Therefore, the single
enzyme phenotypes in CML must be related
to the disease and most likely reflect a clonal
origin for CML. Red cells, platelets, and
cultured monocytes had the same single
enzyme as did the leukaemic granulocytes.
These observations indicate that CML arises
in a stem cell. These conclusions are
supported by investigations of CML patients
with other forms of cellular mosaicism.
Extensive study of Burkitt lymphoma
reveals that in most instances this disease
results from spread throughout the body of a
single malignant clone. Of considerable
interest is the observation that after total
remission some late tumour recurrences
involve clones different from those detectedREPORT OF THE LEUKAEMIA RESEARCH FUND 279
on initial presentation. Thus, these relapses
maybe due tonewoccurrences ofdisease.
These and other studies ofleukaemias and
lymphomata were described and the implica-
tions of the results for the causes of the
malignancies were discussed.
Review Paper: FIAKLOW, P. J., July 4, 1974. The
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291, 26.
CULTURED LYMPHOBLASTOID
LINES AS A MODEL FOR
LEUKAEMIA/LYMPHOMA
C. M. STEEL, M.R.C. Clinical and Population
Cytogenetics Unit, Edinburgh.
With certain notable exceptions, the
lymphoblastoid cell lines established from
biopsies of Burkitt's lymphoma appear, on
cytogenetic and biochemical analysis to be
representative of the tumour cells in this
condition (Gripenberg, Levan and Clifford,
1969; Klein et al., 1968; Fialkow et al.,
1971). Similar lines derived from other
sources have the property of indefinite
proliferation in vitro and may therefore
provide a model for the study ofat least some
aspects of malignancy.
Though little is yet known of the mech-
anisms involved in the transition from
normal lymphocyte to lymphoblastoid cell,
there are consistent differences between the
two cell types which may provide clues to the
nature ofthe transformation process.
Many established lines have a high level of
steroid-binding protein which is also a
characteristic of the malignant cells in acute
lymphoblastic leukaemia. Preliminary data
suggest however that the cytolytic effect of
steroids on some lymphoblasts is not depen-
dent solely on the presence of steroid recep-
tors (Gailani et at., 1973; Lippmann, Berry
and Thompson, 1974).
Changes in the expression of surface
antigens may have an important role in
protection ofthehost againstthe proliferation
of abnormal lymphoid cells in vivo (Golub
et al., 1972; Steel et al., 1974). The antigenic
changes have yet to be fully characterized
but HL-A typing reveals both qualitative
and quantitative alterations in the expression
of transplantation antigens when a cell line
becomes established in culture. Similar
changes have been detected on leukaemic
cells in vivo.
Serial studies on lymphoblastoid lines
show progressive shifts in the expression of
transplantation antigens (Dick et al., 1973).
Other characteristics, including karyotype,
immunoglobulin synthesis and isoenzyme
pattern, also change with time in culture
(Steel, McBeath and O'Riodan, 1971; Evans,
Steel and Arthur, 1974; Povey et al., 1973).
On following genetic markers in individual
lines it is clear that the bulk population in
vitro changes by the emergence of successive
waves of clones. If this is a valid model for
the behaviour ofmalignant cells in vivo it has
important implications for therapy.
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B AND T CELL MEMBRANE
MARKERS IN HUMAN LEUKAEMIAS
AND LYMPHOMATA
M. SELIGMANN, J. C. BROIUET AND J. L.
PREUD'HOMME, Research Institute for Blood
Diseases, HIopital Saint-Louis, Paris.
Cells from patients with leukaemias were
studied using mainly surface immuno-
globulins and IgG aggregates as B cell
markers, spontaneous rosette formation with
sheep red cells and cytotoxic and immuno-
fluorescence tests using heterologous antisera